“The scientific picture is still evolving — but what we see now marks an exciting beginning in understanding rapamycin’s impact on human health and longevity.” New Research Highlights the Expanding Understanding of Rapamycin in Humans A new review study led by Jacob M. Hands at The George Washington University School of Medicine and Health Sciences…

From brain health to personalized medicine, new studies are expanding how rapamycin could shape the next era of longevity science. Here’s what researchers are exploring next. Beyond What We Already Know For years, rapamycin has been the molecule everyone talks about in longevity science — but what comes next might be even more exciting.The first…

By Nicolas Musi, MD — Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio New study by Dr. Nicolas Musi shows rapamycin improves heart and vascular health in older adults, revealing its potential as a cardioprotective longevity therapy. A New Chapter in Rapamycin Research For decades, rapamycin has…

From longevity enthusiasts to cutting-edge scientists, rapamycin is inspiring hope. Here’s how real experiences and future research are shaping the dream of longer, healthier lives. A Movement Beyond the Lab What excites me most about rapamycin right now isn’t just the studies—it’s the people. In longevity forums, podcasts, and private communities, you’ll find countless individuals…

Rapamycin started as a transplant drug, but today it’s being tested in cancer and longevity research. Here’s my take on how this molecule became a true medical revolution. From Soil Sample to Lifesaving Medicine Whenever I read about rapamycin’s history, I can’t help but be amazed. Imagine this: a compound discovered in the soil of…

Recent human studies suggest rapamycin may boost immunity, support brain health, and even influence women’s health. Could this be the first real step toward slowing human aging? A Shift from Mice to Humans For years, I’ve seen headlines about rapamycin extending lifespan in mice. That’s fascinating, of course—but the real question has always been: can…

Low-dose rapamycin shows promising results in ME/CFS patients, improving fatigue, stamina, and immune balance. Could this be a breakthrough treatment for chronic fatigue syndrome? ME/CFS: A Condition Still Waiting for Effective Treatments Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects millions worldwide, leaving patients with severe fatigue, cognitive impairment, and post-exertional malaise. Despite its impact, treatment options…

From Canada’s Discovery to Global Longevity Hype Could one tiny cellular pathway decide how fast we age? Discover how rapamycin and mTOR are reshaping the way we think about longevity and healthy aging. A Cellular “On/Off” Switch for Aging? I’ve always believed that aging isn’t just random—it feels more like a programmed process written into…

Rapamycin has long been studied as a potential longevity drug. But in 2025, the spotlight is shifting toward new and unexpected research directions—far beyond its classic role in slowing aging. Here are some of the most intriguing and lesser-known findings emerging this year: Rapamycin and Alzheimer’s: The First Human Data A recent phase I clinical…

Slowing aging is no longer just science fiction. A newly published scientific study shows that a combination of two FDA-approved drugs—rapamycin and trametinib—can significantly slow down aging and extend lifespan in mice. But here’s the most exciting part: it’s not just about living longer, it’s about living healthier. Two Different Pathways, One Shared Goal: A…